The results from a new study of the multi-kinase inhibitor fexagratinib in mouse models are raising hopes that the therapy ...

Three patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs ...

The groundbreaking new NHS lupus therapy works by genetically modifying cells to enable the body's immune system to recognise ...

Lupus is an 'uncommon, complex, and poorly understood disease' and GPs may not recognise the early warning signs, according ...

Three patients in the UK have received a “groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate ...

Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate ...

Until now, CAR T-cell therapy in the UK has been used only in cancer patients, but researchers believe it could treat range ...

Three patient receive ‘groundbreaking’ lupus treatment in the UK - Around 69,000 people in the UK are thought to have lupus, ...

“The advancement of our pre-clinical pipeline across multiple cell ... Systemic sclerosis (SSc), a type of scleroderma, is a chronic autoimmune disease characterized by inflammation and hardening with ...

The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...

Lupus can range from mild to severe, and leads to patients needing to take drugs for life, with common symptoms including ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...